Necrotizing vasculitis--relapse despite cytotoxic therapy.
The pattern of relapses is described in a consecutive series of 150 patients with vasculitis. Relapse occurred in 42 out of 124 patients who survived for more than 3 months.
Gordon
M
M
Renal Research Laboratory, Queen Elizabeth Hospital, Birmingham.
Luqmani
R A
RA
Adu
D
D
Greaves
I
I
Richards
N
N
Michael
J
J
Emery
P
P
Bacon
P A
PA
D000328:Adult; D000368:Aged; D001167:Arteritis / Q000188:drug therapy / Q000401:mortality; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000188:drug therapy / Q000401:mortality; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D015996:Survival Rate; D014657:Vasculitis / Q000188:drug therapy* / Q000401:mortality
D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone